Insider Transactions in Q1 2026 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2026
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
79,590
-20.12%
|
$1,353,030
$17.73 P/Share
|
|
Jan 12
2026
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,590
+5.05%
|
$636,720
$8.1 P/Share
|
|
Jan 12
2026
|
Kyle Piskel Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,290
-1.94%
|
$77,220
$18.0 P/Share
|
|
Jan 12
2026
|
Kyle Piskel Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,290
+1.9%
|
$51,480
$12.14 P/Share
|
|
Jan 06
2026
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.81%
|
$160,000
$16.44 P/Share
|
|
Jan 05
2026
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
124,998
-4.61%
|
$1,874,970
$15.59 P/Share
|
|
Jan 02
2026
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
3,125
-0.98%
|
$50,000
$16.08 P/Share
|
|
Jan 02
2026
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,125
+0.97%
|
$9,375
$3.99 P/Share
|